Neoplasms

Symptoms and General Pathology

All Conditions

Blood and Lymph Conditions

Immune System Diseases

Behaviors and Mental Disorders

Urinary Tract, Sexual Organs, and Pregnancy Conditions

Rare Diseases

Neoplasm Metastasis

Lymphoma

Caregiver Burden

Urogenital Neoplasms

Urogenital Diseases

Female Urogenital Diseases

Pregnancy Complications

Female Urogenital Diseases and Pregnancy Complications

Male Urogenital Diseases

Lymphosarcoma

Anti-Inflammatory Agents

All Drugs and Chemicals

Triamcinolone

Triamcinolone Acetonide

Triamcinolone hexacetonide

Triamcinolone diacetate

Caregivers of Latino/a advanced cancer patients

The current intervention consists of seven, weekly,45-minute sessions conducted over the telephone using the TAC manual workbook. MSK-approved platforms (such as Webex or Cisco Jabber) can be used for telephone calls in this study. There will be two versions of the intervention used for this study:

1. A culturally tailored version for Latinx participants refined during Phase 1 of this study (available in English and Spanish)
2. A version of the intervention that was not culturally tailored for Latinx patients and caregivers developed in previous work. The two interventions differ in minor content areas. The culturally tailored intervention for Latinx participants and the non-tailored intervention for non-Latinx participants will be used. Interventions will occur weekly with a plus three-week window.

Characteristics of prognostic discussions between patients and caregivers and health providers will be assessed at baseline and post-intervention.

Weekly 45 minute Sessions

Kelly Trevino, PhD

This study will test an intervention to improve patients' and their caregivers' ability to manage difficult emotions and communicate about the patient's illness. There will be two versions of the intervention used for this study: a culturally tailored version for Latinx participants refined during Phase 1 of this study, and a version of the intervention that was not culturally tailored for Latinx patients and caregivers developed in previous work. The two interventions differ in minor content areas. We will use the culturally tailored intervention for Latinx participants and the non-tailored intervention for non-Latinx participants. This culturally sensitive intervention has the potential to reduce Latino/a patient and caregiver distress and improve patient and caregiver quality of life, shared understanding of the patient's illness, and patients' and caregivers' ability to discuss, identify, and document patients' treatment preferences. The intervention is designed to minimize burden to patients, caregivers, and healthcare institutions to allow for easy integration into clinical practice.

An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer

A Communication-Based Intervention for Cancer Patient-Caregiver Dyads to Increase Engagement Treatment Planning and Reduce Caregiver Burden

Weill Medical College of Cornell University

Memorial Sloan Kettering Cancer Center

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer	NCT03794635	Metastatic Canc... Locally Advance... Thoracic Cancer Gynecologic Can... Genitourinary C... Lymphoma	Weekly 45 minut...	18 Years -	Memorial Sloan Kettering Cancer Center
An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer	NCT03794635	Metastatic Canc... Locally Advance... Thoracic Cancer Gynecologic Can... Genitourinary C... Lymphoma	Weekly 45 minut...	18 Years -	Memorial Sloan Kettering Cancer Center
An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer	NCT03794635	Metastatic Canc... Locally Advance... Thoracic Cancer Gynecologic Can... Genitourinary C... Lymphoma	Weekly 45 minut...	18 Years -	Memorial Sloan Kettering Cancer Center

Spots Global Cancer Trial Database for weekly 45 minute sessions